Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1707
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2620
    -0.0002 (-0.02%)
     
  • Bitcoin GBP

    55,271.98
    -717.86 (-1.28%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

Company News for Nov 5, 2020

  • Shares of Clean Harbors Inc. CLH surged 9.7% after the company posted third-quarter 2020 adjusted earnings per share of $0.90, surpassing the Zacks Consensus Estimate of $0.28.

  • Hilton Worldwide Holdings Inc. HLT shares rose 2.7% after the company delivered third-quarter 2020 adjusted earnings per share of $0.06, beating the Zacks Consensus Estimate of a loss per share of $0.09.

  • Radware Ltd RDWR shares jumped 3.8% after the company reported third-quarter 2020 adjusted earnings per share of $0.18, outpacing the Zacks Consensus Estimate of $0.17 per share.

  • Shares of Supernus Pharma. Inc. SUPN rallied 23.8% after the company reported third-quarter 2020 adjusted earnings per share of $0.74, surpassing the Zacks Consensus Estimate of $0.27.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Radware Ltd. (RDWR) : Free Stock Analysis Report
 
Clean Harbors, Inc. (CLH) : Free Stock Analysis Report
 
Supernus Pharmaceuticals, Inc. (SUPN) : Free Stock Analysis Report
 
Hilton Worldwide Holdings Inc. (HLT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research